Patent · US Active

Nucleic acids encoding chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof

US7374912B2 · kind B2 · utility

1Cited by
3References
11Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 20, 2007
Grant dateMay 20, 2008
Priority date
Expiry dateMar 20, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/95
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Chimeric proteins constructed from the fusion of the naturally occurring form of the soluble IL-6 receptor and IL-6 which are useful for treatment of cancer and liver disorders, enhancement of bone marrow transplantation, and treatment of other IL-6 related conditions are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.